Shuttle Pharmaceuticals Holdings, Inc. SHPH
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 9.44M | 8.43M | 7.86M | 6.38M | 6.70M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.22M | 11.18M | 11.92M | 10.91M | 11.69M |
| Operating Income | -11.22M | -11.18M | -11.92M | -10.91M | -11.69M |
| Income Before Tax | -10.26M | -10.82M | -11.72M | -10.71M | -12.14M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.26 | -10.82 | -11.72 | -10.71 | -12.14 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.26M | -10.82M | -11.72M | -10.71M | -12.14M |
| EBIT | -11.22M | -11.18M | -11.92M | -10.91M | -11.69M |
| EBITDA | -9.66M | -10.89M | -11.63M | -10.90M | -11.69M |
| EPS Basic | -27.33 | -57.14 | -128.82 | -200.55 | -190.04 |
| Normalized Basic EPS | -18.32 | -36.49 | -81.28 | -125.34 | -118.78 |
| EPS Diluted | -27.35 | -57.16 | -128.84 | -219.21 | -208.70 |
| Normalized Diluted EPS | -18.32 | -36.49 | -81.28 | -125.34 | -118.78 |
| Average Basic Shares Outstanding | 2.02M | 1.12M | 653.20K | 395.90K | 172.50K |
| Average Diluted Shares Outstanding | 2.02M | 1.12M | 653.20K | 395.90K | 172.50K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |